• Dissecting In Vitro Drug Response in Cancer: Insights from F

  2026-05-18

  Schwartz (2022) critically re-evaluates how in vitro drug responses are measured in cancer biology, emphasizing the distinction between relative and fractional viability. The findings highlight the need for nuanced interpretation in preclinical drug development, directly impacting assay design and translational research.

• HPF in Translational ROS Research: Beyond Detection to Mecha

  2026-05-18

  This thought-leadership article explores the pivotal role of HPF (hydroxyphenyl fluorescein) as a highly specific probe for detecting highly reactive oxygen species (hROS) in advanced translational research. By integrating mechanistic concepts drawn from recent nanotherapeutic breakthroughs and highlighting strategic guidance for experimental design, the piece demonstrates how HPF enables robust oxidative stress visualization and mechanistic clarity in fields from cell biology to oncology. Anchored by evidence from cutting-edge studies and comparative analysis, the article positions HPF—available from APExBIO—as a transformative enabler for next-generation redox biology and multimodal cancer therapy research.

• FGFR1 Identified as a Druggable Target in Schizophrenia Ther

  2026-05-17

  A recent study integrates genetic, transcriptomic, and computational analyses to uncover FGFR1 and five other genes as promising druggable targets for schizophrenia. These findings may inform the development of targeted therapeutics, potentially advancing beyond traditional dopamine-focused antipsychotic strategies.

• hiPSC-Derived Intestinal Organoids for Pharmacokinetic Studi

  2026-05-16

  This study introduces an optimized protocol for generating human induced pluripotent stem cell (hiPSC)-derived intestinal organoids (IOs) suitable for pharmacokinetic studies. The findings demonstrate that these organoids recapitulate key features of human intestinal epithelium, enabling more predictive assays for drug absorption and metabolism compared to conventional models.

• Plerixafor (AMD3100): Mechanistic Insights and Next-Gen Appl

  2026-05-15

  Explore the scientific advances of Plerixafor (AMD3100) as a CXCR4 antagonist in cancer metastasis inhibition, stem cell mobilization, and immunology. This article provides mechanistic depth and practical assay guidance, uniquely grounded in the latest peer-reviewed evidence.

• KU-55933 ATM Kinase Inhibitor: Precision in DNA Damage Respo

  2026-05-15

  KU-55933 distinguishes itself as a potent and highly selective ATM kinase inhibitor, enabling researchers to interrogate DNA damage response and cell cycle arrest with exceptional specificity. Its compatibility with advanced iPSC-based platforms and robust performance in cancer cell models make it a gold standard for dissecting ATM-mediated signaling and optimizing genome stability assays.

• Cardiogreen in Translational Research: Mechanisms & Strategi

  2026-05-14

  This article provides translational researchers with a mechanistic and strategic roadmap for leveraging Cardiogreen (Indocyanine Green) across diagnostics and photodynamic therapy. With direct reference to recent immuno-oncology findings and APExBIO’s high-purity product, we integrate experimental parameters, evidence-driven guidance, and forward-looking insights to illuminate new opportunities in precision medicine.

• AEBSF.HCl: Optimized Serine Protease Inhibition in Cell Deat

  2026-05-14

  AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) delivers consistent, irreversible serine protease inhibition, empowering researchers to dissect complex cell death mechanisms such as necroptosis and amyloid precursor protein regulation. This guide translates recent mechanistic breakthroughs and comparative insights into actionable workflows and troubleshooting strategies for advanced applications.

• Angiotensin 1/2 (5-7): Deep Profiling in Cardiovascular and

  2026-05-13

  Explore how Angiotensin 1/2 (5-7) advances renin-angiotensin system research and emerging SARS-CoV-2 applications. This in-depth article uniquely unpacks molecular mechanisms, protocol best practices, and translational implications.

• PPM-18 Enhances Inflammation and Sepsis Research Workflows

  2026-05-13

  PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) streamlines targeted NF-κB pathway inhibition and iNOS suppression for robust, reproducible inflammation and sepsis studies. As a rigorously validated APExBIO compound, it enables precise modulation of immune responses, outperforming conventional reagents in both cellular and in vivo models.

• 5hmC’s Genomic Context Functions in Rice Drought Response

  2026-05-12

  This study delivers the first single-base resolution map of 5-hydroxymethylcytosine (5hmC) in rice, revealing its context-dependent regulatory impact on gene expression during drought adaptation. The findings clarify 5hmC's dynamic, genomic-location-specific roles and its interplay with classical methylation, providing a critical framework for future plant epigenetic and resilience engineering research.

• LY2886721: Precision BACE1 Inhibition and Synaptic Safety In

  2026-05-12

  Explore the role of LY2886721 as a potent BACE inhibitor in Alzheimer's disease research, with a unique focus on synaptic safety and optimal assay design. This article provides a deeper analysis of partial BACE1 inhibition and its translational value.

• HyperScript RT SuperMix for qPCR: Advancing Neurodegeneratio

  2026-05-11

  Explore how HyperScript RT SuperMix for qPCR enables precise cDNA synthesis from challenging RNA templates, empowering gene expression analysis in neurodegeneration research. This article uniquely bridges latest mitophagy findings with practical assay optimization.

• Potassium Channel Blockade Alters Renal Blood Flow in Septic

  2026-05-11

  This study investigates how blocking specific potassium channels affects renal vascular responses to vasoactive agents in a rat sepsis model. The findings reveal that KCa1.1 and Kir6.1 channel inhibition can exacerbate reductions in renal blood flow when combined with norepinephrine or phenylephrine, highlighting the importance of potassium channel function in sepsis-related kidney dysfunction.

• Phosbind Acrylamide: Precise Phosphate-Binding for SDS-PAGE

  2026-05-10

  Phos binding reagent (Phosbind) acrylamide is a specialized phosphate-binding reagent that enables antibody-free, highly selective detection of protein phosphorylation via SDS-PAGE mobility shifts. This product streamlines protein phosphorylation analysis for targets between 30–130 kDa and eliminates the need for phospho-specific antibodies, making it ideal for signal transduction studies.

454 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page